The Journal of Organic Chemistry
Featured Article
4
4
3
3
ppm): δ 146.7 (d, JCP = 4.7 Hz), 145.5 (d, JCP = 4.7 Hz), 136.7,
18.49, 18.47, 16.57 (d, JCP = 6.0 Hz), 16.55 (d, JCP = 6.0 Hz),
−4.60, −4.64, −4.7. 31P{1H} NMR (121.5 MHz, CDCl3, ppm): δ
30.80 (s, 0.5P), 30.67 (s, 0.5P). FT-IR (neat, cm−1): 3449, 2955,
2929, 2857, 1601, 1495, 1472, 1463, 1448, 1390, 1361, 1248, 1164,
1099, 1056, 1028, 963, 900, 882, 834, 776, 747, 693, 588, 534. HRMS
(ESI-TOF) m/z: [M + Na]+ calcd for C25H41O4PSiNa 487.2404,
found 487.2417.
3
3
136.7, 135.2 (d, JCP = 15.9 Hz), 132.9 (d, JCP = 15.8 Hz), 131.5,
130.9, 128.53, 128.51, 127.5, 126.44, 126.39, 122.52 (dq, 1JCF = 275.9
3
1
3
Hz, JCP = 7.6 Hz), 122.48 (dq, JCF = 275.9 Hz, JCP = 7.6 Hz),
1
3
2
122.47 (dq, JCF2 = 275.9 Hz, JCP = 7.4 Hz), 118.5 (d, JCP = 11.4
5
Hz), 117.0 (d, JCP = 13.0 Hz), 115.4 (d, JCP = 4.3 Hz), 114.0 (d,
5JCP = 3.0 Hz), 76.40 (d, 5JCP = 2.0 Hz), 74.37 (d, 5JCP = 0.6 Hz), 62.2
(dq, 2JCF = 37.7 Hz, 2JCP = 6.5 Hz), 62.13 (dq, 2JCF = 37.7 Hz, 2JCP
=
=
( )-Ethyl 8-((tert-Butyldimethylsilyl)oxy)-2-(diethoxyphosphor-
yl)-6-methyleneoct-4-enoate (3ec). Compounds 1e (203 mg, 0.77
mmol), 2c (40 mg, 0.25 mmol), and Ru3 (8 mg, 0.013 mmol) were
used following general procedure A (ca. 0.05 M). The catalyst was
quenched with methanolic potassium isocyanoacetate, which afforded
3ec after flash chromatography on silica gel (eluent: 20% to 30%
acetone in hexanes) as a pale-yellow oil with a 1.5:1 E/Z ratio (74 mg,
70%). Analytical TLC: Rf = 0.25 (30% acetone in hexanes). 1H NMR
(500 MHz, CDCl3, ppm): δ 8.06−7.99 (m, 2H), 7.56−7.49 (m, 1H),
2
2
1
6.4 Hz), 62.10 (dq, JCF = 37.7 Hz, JCP = 6.9 Hz), 30.8 (d, JCP
1
140.5 Hz), 27.1 (d, JCP = 142.3 Hz), 25.7, 18.3, −4.8, −4. 9, −4.98,
−5.01. 31P{1H} NMR (121.5 MHz, CDCl3, ppm): δ 30.30 (s, minor),
29.35 (s, major). FT-IR (neat, cm−1): 2957, 2931, 2859, 2251, 1720,
1601, 1495, 1472, 1463, 1417, 1362, 1290, 1256, 1171, 1105, 1071,
1006, 963, 908, 880, 835, 777, 732, 693, 649, 602, 556, 520. HRMS
(ESI-TOF) m/z: [M + Na]+ calcd for C24H33F6O4PSiNa 581.1682,
found 581.1690.
3
3
7.44−7.38 (m, 2H), 6.18 (d, JHH = 16.0 Hz, 0.6H), 5.94 (d, JHH
=
Diethyl (7-((tert-Butyldimethylsilyl)oxy)-5-methylenehept-3-en-
1-yl)phosphonate (3df). Compounds 1d (194 mg, 1.01 mmol), 2f
(47 mg, 0.26 mmol), and Ru3 (8 mg, 0.13 mmol) were used
following general procedure B for 3 h. The catalyst was quenched with
methanolic potassium isocyanoacetate, which afforded 3df after flash
chromatography on silica gel (eluent: 40% to 50% ethyl acetate in
hexanes) as a pale-yellow oil with a 1:1.2 E/Z ratio (67 mg, 70%).
11.8 Hz, 0.4H), 5.71 (dt, 3JHH = 16.0 Hz, 3JHH = 7.1 Hz, 0.6H), 5.52
3
3
(dt, JHH = 11.6 Hz, JHH = 6.9 Hz, 0.4H), 5.39 (s, 0.4H), 5.25 (s,
0.6H), 5.16 (s, 1.0H), 4.91 (s, 1.2H), 4.81 (s, 0.8H), 4.20−4.05 (m,
6H), 3.07−2.57 (m, 3H), 1.33−1.26 (m, 6H), 1.23 (t, J = 7.1 Hz,
1.2H), 1.19 (t, J = 7.1 Hz, 1.8H). 13C{1H} NMR (75 MHz, CDCl3,
2
2
ppm): δ 168.6 (d, JCP = 4.7 Hz), 168.5 (d, JCP = 4.7 Hz), 166.2,
166.1, 139.9, 139.5, 133.1 (d, 5JCP = 2.0 Hz), 132.0 (d, 5JCP = 0.5 Hz),
1
Analytical TLC: Rf = 0.20 (50% ethyl acetate in hexanes). H NMR
3
(500 MHz, CDCl3, ppm): δ 6.04 (d, 3JHH = 15.8 Hz, 0.45H), 5.78 (d,
130.10, 130.05, 129.8 (d, JCP = 17.0 Hz), 129.7, 129.91, 129.89,
3
3JHH = 11.6 Hz, 0.55H), 5.67 (dt, JHH = 15.7 Hz, JHH = 6.8 Hz,
3
3
128.43, 128.42, 126.9 (d, JCP = 16.1 Hz), 117.3, 117.1, 67.0, 64.4,
62.9 (d, 2JCP = 6.3 Hz), 62.8 (d, 2JCP = 6.8 Hz), 61.52, 61.46, 46.0 (d,
3
3
0.45H), 5.43 (dt, JHH = 11.6 Hz, JHH = 7.3 Hz, 0.55H), 5.00 (s,
0.55H), 4.92 (s, 0.45H), 4.87 (s, 0.45H), 4.85 (s, 0.55H), 4.12−3.98
(m, 4H), 3.67 (t, 3JHH = 7.2 Hz, 0.9H), 3.62 (t, 3JHH = 7.1 Hz, 1.1H),
1JCP = 130.3 Hz), 45.6 (d, JCP = 129.6 Hz), 30.5 (d, JCP = 4.3 Hz),
1
2
26.3 (d, 2JCP = 4.2 Hz), 16.41 (d, 3JCP = 6.0 Hz), 16.39 (d, 3JCP = 6.0
Hz), 14.16. 31P{1H} NMR (121.5 MHz, CDCl3, ppm): δ 21.28 (s,
major), 21.25 (s, minor). FT-IR (neat, cm−1): 3451, 2982, 2932,
2109, 1721, 1602, 1584, 1451, 1392, 1368, 1315, 1255, 1175, 1153,
1110, 1098, 1022, 967, 860, 792, 713, 688, 674, 651, 559. HRMS
(ESI-TOF) m/z: [M + H]+ calcd for C21H30O7P 425.1714, found
425.1714.
3
2.52−2.43 (m, 1.1H), 2.41−2.31 (m, 0.9H), 2.38 (t, JHH = 7.2 Hz,
0.9H), 2.27 (t, 3JHH = 7.1 Hz, 1.1H), 1.83−1.71 (m, 2H), 1.28 (t, 3JHH
= 7.1 Hz, 2.7H), 1.27 (t, 3JHH = 7.1 Hz, 3.3H), 0.84 (s, 4.05H), 0.84
(s, 4.95H), −0.00 (s, 2.7H), −0.00 (s, 3.3H). 13C{1H} NMR (75
5
MHz, CDCl3, ppm): δ 142.7, 142.0, 132.9 (d, JCP = 1.1 Hz), 131.0
5
3
3
(d, JCP = 1.8 Hz), 130.6 (d, JCP = 17.3 Hz), 128.4 (d, JCP = 17.1
Hz), 115.9, 115.6, 62.5, 62.3, 61.59 (d, 2JCP = 6.4 Hz), 61.58 (d, 2JCP
Ethyl 8-((tert-butyldimethylsilyl)oxy)-2-(diethoxyphosphoryl)-6-
methyleneoct-4-enoate (3ef). Compounds 1e (266 mg, 1.01
mmol), 2f (49 mg, 0.26 mmol), and Ru3 (8 mg, 0.013 mmol)
were used following general procedure A (ca. 0.05 M). The catalyst
was quenched with methanolic potassium isocyanoacetate, which
afforded 3ef after flash chromatography on silica gel (eluent: 45%
ethyl acetate in hexanes) as a pale-yellow oil with a 1.5:1 E/Z ratio
(100 mg, 84%). Analytical TLC: Rf = 0.41 (50% ethyl acetate in
hexanes). 1H NMR (500 MHz, CDCl3, ppm): δ 6.09 (d, 3JHH = 15.8
Hz, 0.6H), 5.85 (d, JHH = 11.7 Hz, 0.4H), 5.59 (dt, JHH = 15.7 Hz,
3JHH = 7.1 Hz, 0.6H), 5.37 (dt, 3JHH = 11.6 Hz, 3JHH = 7.1 Hz, 0.4H),
5.05−5.02 (m, 0.4H), 4.95−4.93 (m, 0.6H), 4.92−4.88 (m, 1H),
4.22−4.07 (m, 6H), 3.66 (t, 3JHH = 7.3 Hz, 1.2H), 3.64 (t, 3JHH = 7.2
Hz, 0.8H), 2.98 (ddd, 2JHP = 22.2 Hz, 3JHH = 11.1 Hz, 3JHH = 4.0 Hz,
1
= 6.4 Hz), 40.7, 35.8, 26.3 (d, JCP = 139.3 Hz), 26.0, 26.0, 25.8 (d,
2JCP = 4.5 Hz), 25.7 (d, JCP = 139.1 Hz), 21.9 (d, JCP = 4.4 Hz),
1
2
18.4, 18.4, 16.6 (d, JCP = 7.0 Hz), −5.16, −5.21. 31P{1H} NMR
3
(121.5 MHz, CDCl3, ppm): δ 30.66 (s, minor), 30.65 (s, major). FT-
IR (neat, cm−1): 3451, 2954, 2929, 2857, 1636, 1472, 1463, 1443,
1390, 1361, 1248, 1164, 1096, 1055, 1027, 962, 894, 834, 813, 775,
736, 663, 542. HRMS (ESI-TOF) m/z: [M + Na]+ calcd for
C18H37O4PSiNa 399.2091, found 399.2102.
3
3
( )-Diethyl ((7E)-6-((tert-Butyldimethylsilyl)oxy)-5-methylene-8-
phenylocta-3,7-dien-1-yl)phosphonate (3dh). Compounds 1d (149
mg, 0.77 mmol), ( )-2h (68 mg, 0.25 mmol), and Ru3 (8 mg, 0.13
mmol) were used following general procedure B for 3 h. The catalyst
was quenched with methanolic potassium isocyanoacetate, which
afforded 3dh after flash chromatography on silica gel (eluent: 35% to
40% ethyl acetate in hexanes) as a pale-yellow oil with a 1:1 E/Z ratio
(92 mg, 79%). Analytical TLC: Rf = 0.30 (50% ethyl acetate in
hexanes). 1H NMR (500 MHz, CDCl3, ppm): δ 7.37−7.32 (m, 2H),
2
3
3
0.6H), 2.94 (ddd, JHP = 22.2 Hz, JHH = 11.1 Hz, JHH = 4.0 Hz,
0.6H), 2.89−2.81 (m, 0.4H), 2.81−2.67 (m, 1H), 2.65−2.56 (m,
3
3
0.6H), 2.36 (t, JHH = 7.3 Hz, 1.2H), 2.29 (t, JHH = 7.1 Hz, 1.8H),
0.86 (s, 9H), 0.02 (s, 2.4H), 0.01 (s, 3.6H). 13C{1H} NMR (75 MHz,
2
2
3
CDCl3, ppm): δ 168.8 (d, JCP = 4.7 Hz), 168.6 (d, JCP = 4.3 Hz),
142.4, 141.8, 134.8 (d, 5JCP = 0.8 Hz), 132.5 (d, 5JCP = 1.4 Hz), 127.6
(d, 3JCP = 15.9 Hz), 125.4 (d, 3JCP = 16.1 Hz), 116.5, 115.9, 62.92 (d,
2JCP = 6.4 Hz), 62.89 (d, 2JCP = 6.2 Hz), 62.8 (d, 2JCP = 6.9 Hz), 62.7
(d, JCP = 7.1 Hz), 62.35, 62.33, 61.49, 61.46, 46.2 (d, JCP = 130.3
Hz), 45.9 (d, JCP = 129.4 Hz), 40.6, 35.7, 30.4 (d, JCP = 4.3 Hz),
7.32−7.27 (m, 2H), 7.23−7.18 (m, 1H), 6.58 (d, JHH = 15.7 Hz,
0.5H), 6.54 (d, 3JHH = 15.8 Hz, 0.5H), 6.19 (dd, 3JHH = 15.8 Hz, 3JHH
= 5.7 Hz, 0.5H), 6.11 (dd, 3JHH = 15.8 Hz, 3JHH = 5.9 Hz, 0.5H), 6.03
3
3
3
(d, JHH = 16.0 Hz, 0.5H), 5.94 (dt, JHH = 15.9 Hz, JHH = 6.6 Hz,
0.5H), 5.89 (d, 3JHH = 11.7 Hz, 0.5H), 5.58 (dt, 3JHH = 11.7 Hz, 3JHH
= 7.2 Hz, 0.5H), 5.36 (s, 0.5H), 5.21 (s, 0.5H), 5.08 (s, 0.5H), 4.98
2
1
1
2
3
3
2
2
(s, 0.5H), 4.93 (d, JHH = 5.5 Hz, 0.5H), 4.71 (d, JHH = 5.7 Hz,
0.5H), 4.13−3.98 (m, 4H), 2.56−2.46 (m, 1H), 2.42−2.32 (m, 1H),
1.85−1.70 (m, 2H), 1.30 (t, 3JHH = 6.9 Hz, 1.5H), 1.30 (t, 3JHH = 7.3
26.2 (d, JCP = 4.3 Hz), 26.0, 18.40, 18.37, 16.46 (d, JCP = 6.0 Hz),
16.44 (d, JCP = 6.2 Hz), 14.25, 14.23, −5.20, −5.23. 31P{1H} NMR
2
(121.5 MHz, CDCl3, ppm): δ 21.42 (s, minor), 21.37 (s, major). FT-
IR (neat, cm−1): 2955, 2930, 2857, 1734, 1607, 1472, 1444, 1390,
1368, 1327, 1252, 1152, 1096, 1023, 967, 894, 834, 812, 775, 732,
663, 602, 566. High-resolution MS HRMS (ESI-TOF) m/z: [M +
Na]+ calcd for C21H41O6PSiNa 471.2302, found 471.2314.
3
3
Hz, 1.5H), 1.29 (t, JHH = 7.0 Hz, 1.5H), 1.28 (t, JHH = 7.3 Hz,
1.5H), 0.92 (s, 9H), 0.8 (s, 4H), 0.7 (s, 2H). 13C{1H} NMR (75
3
MHz, CDCl3, ppm): δ 147.5, 146.2, 137.1, 137.0, 132.3 (d, JCP
=
17.8 Hz), 132.1, 132.0, 129.9 (d, 3JCP = 17.5 Hz), 129.6, 129.5, 129.4
(d, 5JCP = 1.4 Hz), 128.61, 128.59, 127.51, 127.49, 127.4 (d, 5JCP = 1.9
Hz), 126.57, 126.57, 113.3, 113.1, 76.7, 74.4, 61.60 (d, 2JCP = 6.5 Hz),
6-((tert-Butyldimethylsilyl)oxy)-4-methylenehex-2-en-1-yl dieth-
yl Phosphate (3ff). Compounds 1f (198 mg, 1.02 mmol), 2f (48 mg,
0.26 mmol), and Ru3 (8 mg, 0.013 mmol) were used following
general procedure A (ca. 0.05 M). The catalyst was quenched with
2
2
1
61.57 (d, JCP = 6.4 Hz), 26.21 (d, JCP = 1.1 Hz), 26.17 (d, JCP
139.1 Hz), 26.0, 25.6 (d, JCP = 139.0 Hz), 21.1 (d, JCP = 1.1 Hz),
=
1
5
1380
J. Org. Chem. 2021, 86, 1371−1384